https://doi.org/10.18502/ijrm.v22i1.15243
statistics
- 172 Abstract Views
- 107 PDF Views
- 0 HTML Views
authors
-
Farzad Soheilipour
Farzad Soheilipour
Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
-
Sohrab Boozarpour
Sohrab Boozarpour
Department of Biology, Faculty of Basic Sciences, Gonbad Kavous University, Gonbad Kavous, Iran.
-
Shiva Aghaei
Shiva Aghaei
Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
-
Ehsan Farashahi Yazd
Ehsan Farashahi Yazd
Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Published Date
- Feb 18, 2024
The genetically modified human foreskin fibroblast cell line (YhFF#8) stably expressing Cas9 gene: A lab resource report
Abstract
Background: Stable Cas9 (CRISPR-associated protein 9)-expressing cell lines have emerged as valuable tools in genetic research, enhancing the efficiency of the CRISPR/Cas9 system and streamlining gene editing procedures. These cell lines enable simultaneous editing of multiple genes and reduce the overall editing time.
Objective: This study aimed to develop a stable human fibroblast cell line capable of genetic conversion into a mutant form, serving as a cellular model for a specific genetic disease. The established cell line facilitates investigation of disease mechanisms, testing of potential treatments, and gaining insights into underlying molecular processes.
Materials and Methods: Human embryonic kidney 293LTV cells were used to produce pseudo-virus particles, while Yazd human foreskin fibroblasts batch 8 (YhFF#8) cells were targeted for genetic modification. Transfection of human embryonic kidney 293LTV cells with pCDH-Cas9 plasmid DNA generated pseudo-viral particles. YhFF#8 cells were transduced and selected using antibiotics. Green fluorescent protein (GFP) detection confirmed successful transduction and selection. Relative expression levels of the Cas9 gene were determined by quantitative polymerase chain reaction.
Results: The study validated the fidelity of the Cas9 gene cassette sequence and its transcriptional activity. Transduced YhFF#8 cells exhibited green fluorescence, with antibiotic selection resulting in nearly 100% transduced cells. A reporter GFP gene enabled real-time monitoring of YhFF#8-Cas9-GFP-PuroR cells using fluorescence microscopy.
Conclusion: YhFF#8-Cas9-GFP-PuroR cells, labeled and susceptible to genomic editing, provide an optimal source for generating induced pluripotent stem cell lines for future biomedical research.
Key words: Fibroblasts, Cell line, Genetic transduction, CRISPR-Cas9.
References
[2] Capes-Davis A, Bairoch A, Barrett T, Burnett EC, Dirks WG, Hall EM, et al. Cell lines as biological models: Practical steps for more reliable research. Chem Res Toxicol 2019; 32: 1733–1736.
[3] Dumont J, Euwart D, Mei B, Estes S, Kshirsagar R. Human cell lines for biopharmaceutical manufacturing: History, status, and future perspectives. Crit Rev Biotechnol 2016; 36: 1110–1122.
[4] Genzel Y. Designing cell lines for viral vaccine production: Where do we stand? Biotechnol J 2015; 10: 728–740.
[5] Peng Y, Ma A, Xiao Zh, Hao J, Feng R, Wang Ch, et al. Technical specifications for ethics review of human stem cell research. Cell Prolif 2023: e13556.
[6] Xu Y, Li Zh. CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. Comput Struct Biotechnol J 2020; 18: 2401–2415.
[7] Caneparo Ch, Baratange C, Chabaud S, Bolduc S. Conditioned medium produced by fibroblasts cultured in low oxygen pressure allows the formation of highly structured capillary-like networks in fibrin gels. Sci Rep 2020; 10: 9291.
[8] Fernandes IR, Russo FB, Pignatari GC, Evangelinellis MM, Tavolari S, Muotri AR, et al. Fibroblast sources: Where can we get them? Cytotechnology 2016; 68: 223–228.
[9] Mesdom P, Colle R, Lebigot E, Trabado S, Deflesselle E, Fève B, et al. Human dermal fibroblast: A promising cellular model to study biological mechanisms of major depression and antidepressant drug response. Curr Neuropharmacol 2020; 18: 301–318.
[10] Han X, Liu Z, Jo MC, Zhang K, Li Y, Zeng Z, et al. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation. Sci Adv 2015; 1: e1500454.
[11] DeWitt MA, Corn JE, Carroll D. Genome editing via delivery of Cas9 ribonucleoprotein. Methods 2017; 121–122: 9–15.
[12] Suchý T, Kaczmarek I, Maricic T, Zieschang C, Schöneberg T, Thor D, et al. Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines. Adipocyte 2021; 10: 631–645.
[13] Javaid N, Choi S. CRISPR/Cas system and factors affecting its precision and efficiency. Front Cell Dev Biol 2021; 9: 761709.
[14] Aregger M, Chandrashekhar M, Tong AHY, Chan K, Moffat J. Pooled lentiviral CRISPR-Cas9 screens for functional genomics in Mammalian cells. Methods Mol Biol 2018; 1869: 169–188.
[15] Yu H, Wu Zh, Chen X, Ji Q, Tao Sh. CRISPR-CBEI: A designing and analyzing tool kit for cytosine base editor-mediated gene inactivation. MSystems 2020; 5: e00350–20.
[16] Dong W, Kantor B. Lentiviral vectors for delivery of gene-editing systems based on CRISPR/Cas: Current state and perspectives. Viruses 2021; 13: 1288.
[17] Liao JQ, Zhou G, Zhou Y. Generation of monoclonal iPSC lines with stable Cas9 expression and high Cas9 activity. Methods Mol Biol 2022; 2454: 575–588.
[18] Aubrey BJ, Kelly GL, Kueh AJ, Brennan MS, O’Connor L, Milla L, et al. An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. Cell Rep 2015; 10: 1422–1432.
[19] Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
[20] Fernandez JP, Vejnar ChE, Giraldez AJ, Rouet R, Moreno-Mateos MA. Optimized CRISPR-Cpf1 system for genome editing in zebrafish. Methods 2018; 150: 11–18.
[21] Lino CA, Harper JC, Carney JP, Timlin JA. Delivering CRISPR: A review of the challenges and approaches. Drug Deliv 2018; 25: 1234–1257.
[22] Campa CC, Weisbach NR, Santinha AJ, Incarnato D, Platt RJ. Multiplexed genome engineering by Cas12a and CRISPR arrays encoded on single transcripts. Nat Methods 2019; 16: 887–893.
[23] Lo ChA, Greben AW, Chen BE. Generating stable cell lines with quantifiable protein production using CRISPR/Cas9-mediated knock-in. Biotechniques 2017; 62: 165–174.
[24] Hajizadeh-Tafti F, Golzadeh J, Farashahi-Yazd E, Heidarian-Meimandi H, Aflatoonian B. Established Yazd human foreskin fibroblast lines (#8, #17, and #18) displaying similar characteristics to mesenchymal stromal cells: A lab resources report. Int J Reprod BioMed 2022; 20: 519–528.
[25] Ryø LB, Thomsen EA, Mikkelsen JG. Production and validation of lentiviral vectors for CRISPR/Cas9 delivery. Methods Mol Biol 2019; 1961: 93–109.
[26] Wang X, Xu Zh, Tian Zh, Zhang X, Xu D, Li Q, et al. The EF-1a promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells. J Cell Mol Med 2017; 21: 3044–3054.
[27] Wen J, Wu J, Cao T, Zhi S, Chen Y, Aagaard L, et al. Methylation silencing and reactivation of exogenous genes in lentivirus-mediated transgenic mice. Transgenic Res 2021; 30: 63–76.
[28] Ellis J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 2005; 16: 1241–1246.
[29] Schlesinger Sh, Goff SP. Silencing of proviruses in embryonic cells: Efficiency, stability and chromatin modifications. EMBO Rep 2013; 14: 73–79.
[30] Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, Zavidij O, et al. Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 2012; 20: 1014–1021.
[31] Khacho M, Mekhail K, Pilon-Larose K, Pause A, Côté J, Lee S. eEF1A is a novel component of the mammalian nuclear protein export machinery. Mol Biol Cell 2008; 19: 5296–5308.